Literature DB >> 457253

Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin.

P M Schlievert, D J Schoettle, D W Watson.   

Abstract

A staphylococcal pyrogenic exotoxin was purified and characterized biochemically and biologically. The organism producing the toxin was a group I Staphylococcus aureus strain which was isolated from a vaginal infection of a patient with mucocutaneous lymph node syndrome (Kawasaki's disease). The possible association of the toxin with the disease syndrome is discussed. The toxin was purified from cell-free culture supernatant fluids by means of differential precipitation with ethanol and resolubilization in pyrogen-free distilled water followed by preparative thin-layer isoelectric focusing. The pyrogenic exotoxin produced fevers in both rabbits and mice and enhanced host susceptibility to lethal shock and myocardial and liver damage by endotoxin. Also, the toxin was a potent nonspecific lymphocyte mitogen, stimulating rabbit spleen cells and human cord blood lymphocytes to proliferate. The toxin migrated as a homogeneous protein when tested with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (molecular weight, 12,000) and reisoelectric focusing (pI 5.3). Hyperimmune antisera raised against the purified toxin reacted with ethanol-precipitated toxin, using immunodiffusion to form a single precipitin arc. The toxin was distinguished from other staphylococcal toxins by a variety of methods. The amino acid composition was determined.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 457253      PMCID: PMC414209          DOI: 10.1128/iai.23.3.609-617.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  ENHANCEMENT OF BACTERIAL ENDOTOXIN LETHALITY BY STAPHYLOCOCCAL ENTEROTOXIN.

Authors:  H SUGIYAMA; E M MCKISSIC; M S BERGDOLL; B HELLER
Journal:  J Infect Dis       Date:  1964-04       Impact factor: 5.226

2.  Further studies of group A streptococcal factors with lethal and cardiotoxic properties.

Authors:  J H SCHWAB; D W WATSON; W J CROMARTIE
Journal:  J Infect Dis       Date:  1955 Jan-Feb       Impact factor: 5.226

3.  Enterotoxin produced by micrococci from cases of enteritis after antibiotic therapy.

Authors:  M J SURGALLA; G M DACK
Journal:  J Am Med Assoc       Date:  1955-06-25

4.  Isolation and composition of staphylococcal alpha toxin.

Authors:  A W BERNHEIMER; L L SCHWARTZ
Journal:  J Gen Microbiol       Date:  1963-03

5.  Fractionation of a leucocidin from Staphylococcus aureus.

Authors:  A M WOODIN
Journal:  Biochem J       Date:  1959-10       Impact factor: 3.857

6.  Studies with staphylococcal toxins. I. A reappraisal of the validity of the kitten test as an indication of staphylococcal enterotoxin.

Authors:  B H MATHESON; F S THATCHER
Journal:  Can J Microbiol       Date:  1955-06       Impact factor: 2.419

7.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

8.  STUDIES IN STAPHYLOCOCCAL FEVER. II. RESPONSES TO CULTURE FILTRATES.

Authors:  E ATKINS
Journal:  Yale J Biol Med       Date:  1963-06

9.  Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock.

Authors:  P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

10.  Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins.

Authors:  D W WATSON
Journal:  J Exp Med       Date:  1960-02-01       Impact factor: 14.307

View more
  30 in total

1.  Residues 20, 22, and 26 determine the subtype specificities of staphylococcal enterotoxins C1 and C2.

Authors:  T N Turner; C L Smith; G A Bohach
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

2.  Nucleotide sequence of the staphylococcal enterotoxin C1 gene and relatedness to other pyrogenic toxins.

Authors:  G A Bohach; P M Schlievert
Journal:  Mol Gen Genet       Date:  1987-08

3.  Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1.

Authors:  W F Keane; G Gekker; P M Schlievert; P K Peterson
Journal:  Am J Pathol       Date:  1986-01       Impact factor: 4.307

4.  Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies.

Authors:  G A Bohach; C J Hovde; J P Handley; P M Schlievert
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

5.  Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

Review 6.  Toxic shock syndrome in Canada.

Authors:  A J Clayton; J E Peacocke; P E Ewan
Journal:  Can Med Assoc J       Date:  1982-04-01       Impact factor: 8.262

7.  Toxic shock syndrome.

Authors:  M H Tanner; B J Pierce; D C Hale
Journal:  West J Med       Date:  1981-06

Review 8.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

9.  Characterization of novel type C staphylococcal enterotoxins: biological and evolutionary implications.

Authors:  J C Marr; J D Lyon; J R Roberson; M Lupher; W C Davis; G A Bohach
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Characterization of Staphylococcus aureus isolates from patients with toxic shock syndrome, using polyethylene infection chambers in rabbits.

Authors:  D F Scott; J M Kling; J J Kirkland; G K Best
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.